195 research outputs found

    Conforming to the will of the church: The role of religious orientation, religious proscription, and right-wing authoritarianism in the religion-prejudice relationship

    Get PDF
    Study 1 was designed to determine the relationships between three religious orientations and three measures of prejudice. Contrary to previous findings, religious Quest (Q) was not negatively correlated with 2 measures of ethnocentrism. However, the associations among dependent measures of religiously proscribed and nonproscribed prejudices, and Intrinsic (I) and Extrinsic (E) religious orientations, supported previous findings. Study 1 also was intended to examine the role of “right-wing authoritarianism” (RWA) and “social desirability’ (SD) in the religion-prejudice relationship. Contrary to Batson, Schoenrade, and Ventis (1993), no correlational evidence was found to support the hypothesis that highly intrinsic believers are prone to responding in a socially desirable way on overt questionnaire measures of prejudice, however, RWA was positively related to I. When the effect of RWA was controlled in a partial correlation procedure, the negative correlation between self-reported I and ethnocentrism became significantly stronger, while a positive relationship between self-reported I and nonproscribed prejudice was eliminated. Partial correlations between E, Q, and prejudice shifted in a “more prejudiced” direction for both proscribed and nonproscribed measures of prejudice. Study 2 compared behavioural prejudice responses (choosing a black vs. white, and homosexual vs. heterosexual interviewer) with measures of prejudice from Study 1. For proscribed prejudice, self- reported ethnocentrism was not a predictor of discrimination. For nonproscribed prejudice, choosing a heterosexual over a homosexual interviewer was associated with self-reported homophobic attitudes. Finally, results of Study 2 did not support our hypothesis that the I-prejudice relationship is mediated by authoritarian (RWA) attitudes

    Simvastatin Enhances Immune Responses to Aβ Vaccination and Attenuates Vaccination-Induced Behavioral Alterations

    Get PDF
    Statins are widely used to lower cholesterol levels by inhibiting cholesterol biosynthesis. Some evidence has indicated that statins might have therapeutic and preventive benefits for Alzheimer\u27s disease (AD). We and others also have shown the beneficial effect of statin treatment in reversing learning and memory deficits in animal models of AD. However, data from clinical trials are inconclusive. We previously documented that the adenovirus vector encoding 11 tandem repeats of Aβ1-6 fused to the receptor-binding domain (Ia) of Pseudomonas exotoxin A, AdPEDI-(Aβ1-6)(11), is effective in inducing an immune response against amyloid-β protein (Aβ) and reducing brain Aβ load in Alzheimer\u27s mouse models. In the present study, we examined whether the administration of simvastatin can modulate immune and behavioral responses of C57BL/6 mice to vaccination. Simvastatin was given to the animals as a diet admixture for four weeks, followed by nasal vaccination with AdPEDI-(Aβ1-6)(11) once per week for four weeks. The cholesterol-lowering action of simvastatin was monitored by measuring the cholesterol levels in plasma. Simvastatin significantly increased the number of the mice responding to vaccination compared with the mice receiving only AdPEDI-(Aβ1-6)(11). Immunoglobulin isotyping revealed that the vaccination predominantly induced Th2 immune responses. Simvastatin treatment prevented Aβ-induced production of IFN-γ in splenocytes. The adenovirus vaccination altered mouse behavior in T- and elevated plus-maze tests and simvastatin counteracted such behavioral changes. Our results indicate that simvastatin clearly enhances the immune responses of C57BL/6 mice to the nasal vaccination with AdPEDI-(Aβ1-6)(11). Simvastatin may be effective in preventing behavioral changes associated with vaccination

    Do Girls and Boys Perceive Themselves as Equally Engaged in School? The Results of an International Study from 12 Countries

    Get PDF
    This study examined gender differences in student engagement and academic performance in school. Participants included 3420 students (7th, 8th, and 9th graders) from Austria, Canada, China, Cyprus, Estonia, Greece, Malta, Portugal, Romania, South Korea, the United Kingdom, and the United States. The results indicated that, compared to boys, girls reported higher levels of engagement in school andwere rated higher by their teachers in academic performance. Student engagement accounted for gender differences in academic performance, but gender did not moderate the associations among student engagement, academic performance, or contextual supports. Analysis of multiple-group structural equation modeling revealed that perceptions of teacher support and parent support, but not peer support, were related indirectly to academic performance through student engagement. This partial mediation model was invariant across gender. The findings from this study enhance the understanding about the contextual and personal factors associated with girls' and boys' academic performance around the world

    The First Comprehensive Photometric Study of the Algol-type System CL Aurigae

    Full text link
    We present the first extensive photometric results of CL Aur from our BVRI CCD photometry made on 22 nights from 2003 November through 2005 February. Fifteen new timings of minimum light were obtained. During the past 104 years, the orbital period has varied due to a periodic oscillation superposed on a continuous period increase. The period and semi-amplitude of the oscillation are about 21.6 yrs and 0.0133 d, respectively. This detail is interpreted as a light-travel-time effect due to a low-luminosity K-type star gravitationally bound to the CL Aur close system. Our photometric study indicates that CL Aur is a relatively short-period Algol-type binary with values of q=0.602 and i=88^\circ.2. Mass transfer from the secondary to the primary eclipsing component is at least partly responsible for the observed secular period change with a rate of dP/dt = +1.4×107\times10^{-7} d yr1^{-1}. A cool spot model has been calculated but we think that an alternative hot-spot model resulting from a gas stream impact on the hot star is more reasonable despite two difficulties with the explanation. Absolute dimensions of the eclipsing system are deduced and its present state is compared with tracks for single star and conservative close binary evolution. Finally, we examine the possible reconciliation of two different calculations of the luminosity of the hot spot and a re-interpretation of the secular term of the period variability.Comment: 26 pages, including 5 figures and 9 tables, accepted for publication in A

    TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Amyloid plaques, a pathological hallmark of Alzheimer's disease (AD), are accompanied by activated microglia. The role of activated microglia in the pathogenesis of AD remains controversial: either clearing Aβ deposits by phagocytosis or releasing proinflammatory cytokines and cytotoxic substances. Microglia can be activated via toll-like receptors (TLRs), a class of pattern-recognition receptors in the innate immune system. We previously demonstrated that an AD mouse model homozygous for a loss-of-function mutation of TLR4 had increases in Aβ deposits and buffer-soluble Aβ in the brain as compared with a TLR4 wild-type AD mouse model at 14-16 months of age. However, it is unknown if TLR4 signaling is involved in initiation of Aβ deposition as well as activation and recruitment of microglia at the early stage of AD. Here, we investigated the role of TLR4 signaling and microglial activation in early stages using 5-month-old AD mouse models when Aβ deposits start.</p> <p>Methods</p> <p>Microglial activation and amyloid deposition in the brain were determined by immunohistochemistry in the AD models. Levels of cerebral soluble Aβ were determined by ELISA. mRNA levels of cytokines and chemokines in the brain and Aβ-stimulated monocytes were quantified by real-time PCR. Cognitive functions were assessed by the Morris water maze.</p> <p>Results</p> <p>While no difference was found in cerebral Aβ load between AD mouse models at 5 months with and without TLR4 mutation, microglial activation in a TLR4 mutant AD model (TLR4M Tg) was less than that in a TLR4 wild-type AD model (TLR4W Tg). At 9 months, TLR4M Tg mice had increased Aβ deposition and soluble Aβ42 in the brain, which were associated with decrements in cognitive functions and expression levels of IL-1β, CCL3, and CCL4 in the hippocampus compared to TLR4W Tg mice. TLR4 mutation diminished Aβ-induced IL-1β, CCL3, and CCL4 expression in monocytes.</p> <p>Conclusion</p> <p>This is the first demonstration of TLR4-dependent activation of microglia at the early stage of β-amyloidosis. Our results indicate that TLR4 is not involved in the initiation of Aβ deposition and that, as Aβ deposits start, microglia are activated via TLR4 signaling to reduce Aβ deposits and preserve cognitive functions from Aβ-mediated neurotoxicity.</p

    Low CRB-65 scores effectively rule out adverse clinical outcomes in COVID-19 irrespective of chest radiographic abnormalities

    Get PDF
    Background: CRB-65 ( C onfusion; R espiratory rate ≥ 30/min; B lood pressure ≤ 90/60 mmHg; age ≥ 65 years) is a risk score for prognosticating patients with COVID-19 pneumonia. However, a significant proportion of COVID-19 patients have normal chest X-rays (CXRs). The influence of CXR abnormalities on the prognostic value of CRB-65 is unknown, limiting its wider applicability. Methods: We assessed the influence of CXR abnormalities on the prognostic value of CRB-65 in COVID-19. Results: In 589 study patients (71 years (IQR: 57–83); 57% males), 186 (32%) had normal CXRs. On ROC analysis, CRB-65 performed similarly in patients with normal vs. abnormal CXRs for predicting inpatient mortality (AUC 0.67 ± 0.05 vs. 0.69 ± 0.03). In patients with normal CXRs, a CRB-65 of 0 ruled out mortality, NIV requirement and critical illness (intubation and/or ICU admission) with negative predictive values (NPVs) of 94%, 98% and 99%, respectively. In patients with abnormal CXRs, a CRB-65 of 0 ruled out the same endpoints with NPVs of 91%, 83% and 86%, respectively. Patients with low CRB-65 scores had better inpatient survival than patients with high CRB-65 scores, irrespective of CXR abnormalities (all p < 0.05). Conclusions: CRB-65, CXR and CRP are independent predictors of mortality in COVID-19. Adding CXR findings (dichotomised to either normal or abnormal) to CRB-65 does not improve its prognostic accuracy. A low CRB-65 score of 0 may be a good rule-out test for adverse clinical outcomes in COVID-19 patients with normal or abnormal CXRs, which deserves prospective validation.Publisher PDFPeer reviewe

    ADHERE: randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus

    Get PDF
    ADHERE was a randomized, open-label, Phase IV study comparing renal function at Week 52 postkidney transplant, in patients who received prolongedrelease tacrolimus-based immunosuppressive regimens. On Days 0?27, patients received prolonged-release tacrolimus (initially 0.2 mg/kg/day), corticosteroids, and mycophenolate mofetil (MMF). Patients were randomized on Day 28 to receive either prolonged-release tacrolimus plus MMF (Arm 1) or prolongedrelease tacrolimus (?25% dose reduction on Day 42) plus sirolimus (Arm 2). The primary endpoint was glomerular filtration rate by iohexol clearance (mGFR) at Week 52. Secondary endpoints included eGFR, creatinine clearance (CrCl), efficacy failure (patient withdrawal or graft loss), and patient/graft survival. Tolerability was analyzed. The full-analysis set comprised 569 patients (Arm 1: 287; Arm 2: 282). Week 52 mean mGFR was similar in Arm 1 versus Arm 2 (40.73 vs. 41.75 ml/min/1.73 m2; P = 0.405), as were the secondary endpoints, except composite efficacy failure, which was higher in Arm 2 versus 1 (18.2% vs. 11.5%; P = 0.002) owing to a higher postrandomization withdrawal rate due to adverse events (AEs) (14.4% vs. 5.2%). Results from this study show comparable renal function between arms at Week 52, with fewer AEs leading to study discontinuation with prolonged-release tacrolimus plus MMF (Arm 1) versus lower dose prolonged-release tacrolimus plus sirolimus (Arm 2)
    corecore